The FiiRST-2 randomised trial compared fibrinogen and prothrombin complex concentrate with plasma in trauma patients needing massive transfusion. No significant benefit was found.
Factors in the Initial Resuscitation of Patients With Severe Trauma – The FiiRST-2 Trial Read More
This post is co-published with our friends at REBEL EM. Background: It almost seems that when it comes to the use of the antifibrinolytic agent tranexamic acid (TXA) in trauma,
JC: Should we rubber STAAMP prehospital TXA? Read More
Bleeding trauma patients present a couple of challenges to us in the Emergency Department. Increasingly, our aging population continues to engage in energetic daily pursuits while increasing numbers are prescribed
JC: Blood Products in Trauma – What’s the Best (I)TACTIC? Read More
Tranexamic Acid (TXA) is a mainstay of trauma management. CRASH 2 (2) demonstrated its effectiveness in bleeding patients and CRASH 3 (1,5) (in my opinion) showed that we should also
JC: Can we give tranexamic acid (TXA) via the IM route? St Emlyn’s Read More
